Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
April 28, 2025
Off-label use of intravenous rifampicin during surgery: analysis of Australian surveillance data and retrospective audit at a tertiary hospital
Nadine T Hillock, Edward Raby, Matthew Rawlins
Jac-Antimicrobial Resistance
|
March 5, 2025
Do policies that allow access to unregistered antimicrobials address the unmet need? Australia as a case study of a high-income country with universal healthcare
Nadine T Hillock, Allen Cheng, Andrew Bowskill
Infection, Disease & Health
|
January 3, 2026
Management, use and documentation of off-label antimicrobials in the operating theatre: A survey of Australian hospital pharmacists
Nadine T Hillock, Matthew Rawlins, Edward Raby, et al.
Jac-Antimicrobial Resistance
|
July 5, 2021
Comparative analysis of Australian hospital antimicrobial utilization, using the WHO AWaRe classification system and the adapted Australian Priority Antimicrobial List (PAL)
Nadine T Hillock, Erin Connor, Courtenay Wilson, et al.
Applied Health Economics and Health Policy
|
April 4, 2022
Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy
Nadine T Hillock, Tracy L Merlin, John Turnidge, et al.
Infection, Disease & Health
|
January 9, 2020
Estimating the utilisation of unregistered antimicrobials in Australia
Nadine T Hillock, Jonathan Karnon, John Turnidge, et al.
Asia-Pacific Journal of Clinical Oncology
|
December 17, 2016
Infliximab for ipilimumab-induced colitis: A series of 13 patients
Nadine T Hillock, Sharryn Heard, Ganessan Kichenadasse, et al.
Jac-Antimicrobial Resistance
|
July 5, 2021
Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study
Nadine T Hillock, Tracy L Merlin, Jonathan Karnon, et al.
International Journal of Technology Assessment in Health Care
|
November 3, 2020
Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective
Nadine T Hillock, Tracy L Merlin, Jonathan Karnon, et al.
Australian Health Review : a Publication of the Australian Hospital Association
|
July 6, 2019
Clinical indications treated with unregistered antimicrobials: regulatory challenges of antimicrobial resistance and access to effective treatment for patients
Nadine T Hillock, Lisa Paradiso, John Turnidge, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
April 28, 2025
Off-label use of intravenous rifampicin during surgery: analysis of Australian surveillance data and retrospective audit at a tertiary hospital
Nadine T Hillock, Edward Raby, Matthew Rawlins
Jac-Antimicrobial Resistance
|
March 5, 2025
Do policies that allow access to unregistered antimicrobials address the unmet need? Australia as a case study of a high-income country with universal healthcare
Nadine T Hillock, Allen Cheng, Andrew Bowskill
Infection, Disease & Health
|
January 3, 2026
Management, use and documentation of off-label antimicrobials in the operating theatre: A survey of Australian hospital pharmacists
Nadine T Hillock, Matthew Rawlins, Edward Raby, et al.
Jac-Antimicrobial Resistance
|
July 5, 2021
Comparative analysis of Australian hospital antimicrobial utilization, using the WHO AWaRe classification system and the adapted Australian Priority Antimicrobial List (PAL)
Nadine T Hillock, Erin Connor, Courtenay Wilson, et al.
Applied Health Economics and Health Policy
|
April 4, 2022
Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy
Nadine T Hillock, Tracy L Merlin, John Turnidge, et al.
Infection, Disease & Health
|
January 9, 2020
Estimating the utilisation of unregistered antimicrobials in Australia
Nadine T Hillock, Jonathan Karnon, John Turnidge, et al.
Asia-Pacific Journal of Clinical Oncology
|
December 17, 2016
Infliximab for ipilimumab-induced colitis: A series of 13 patients
Nadine T Hillock, Sharryn Heard, Ganessan Kichenadasse, et al.
Jac-Antimicrobial Resistance
|
July 5, 2021
Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study
Nadine T Hillock, Tracy L Merlin, Jonathan Karnon, et al.
International Journal of Technology Assessment in Health Care
|
November 3, 2020
Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective
Nadine T Hillock, Tracy L Merlin, Jonathan Karnon, et al.
Australian Health Review : a Publication of the Australian Hospital Association
|
July 6, 2019
Clinical indications treated with unregistered antimicrobials: regulatory challenges of antimicrobial resistance and access to effective treatment for patients
Nadine T Hillock, Lisa Paradiso, John Turnidge, et al.
Page
of 2